Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on SalesTimes Interest Earned

Global Medical REIT (GMRE-PB) EBITDA Margin (2016 - 2025)

Global Medical REIT (GMRE-PB) has disclosed EBITDA Margin for 10 consecutive years, with 131.85% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA Margin rose 1633920.0% year-over-year to 131.85%, compared with a TTM value of 24996.77% through Dec 2025, down 2545239.0%, and an annual FY2025 reading of 24996.77%, up 825485.0% over the prior year.
  • EBITDA Margin was 131.85% for Q4 2025 at Global Medical REIT, up from 55.69% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 143.8% in Q3 2022 and bottomed at 193750.0% in Q4 2022.
  • Average EBITDA Margin over 5 years is 15452.31%, with a median of 24.52% recorded in 2022.
  • The sharpest move saw EBITDA Margin tumbled -19377946bps in 2022, then surged 19383054bps in 2023.
  • Year by year, EBITDA Margin stood at 29.46% in 2021, then tumbled by -657701bps to 193750.0% in 2022, then skyrocketed by 100bps to 80.54% in 2023, then plummeted by -20223bps to 16207.35% in 2024, then skyrocketed by 101bps to 131.85% in 2025.
  • Business Quant data shows EBITDA Margin for GMRE-PB at 131.85% in Q4 2025, 55.69% in Q3 2025, and 38606.74% in Q2 2025.